AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Injection

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures NCT05744336NA1 site📍 Chicago Northwestern University · Tests: Group 1 Immersive Virtual Reality (VR), Group 2 Control Group Suprazygomatic Maxillary Nerve Block in Pediatric Tonsillectomy NCT07176533NA1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Suprazygomatic maxillary nerve block (SZMN) with bupivacaine, Suprazygomatic maxillary nerve block (SZMN) with placebo An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease NCT06272149EARLY Phase 11 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… · Tests: VGN-R08b SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC NCT07284992Phase 21 site📍 Jinan Shandong Provincial Hospital · Tests: short-term radiotherapy combined with Adebrelimab and capox, long-term radiotherapy combined with Adebrelimab and capox The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease NCT06608355Phase 11 site📍 Wuhan iRegene Therapeutics Co., Ltd. · Tests: Human Dopaminergic Progenitor Cells A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis NCT07499700Phase 2, Phase 31 site📍 Beijing Bio-Thera Solutions · Tests: BAT4406F, Placebos Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer NCT07367516Phase 1, Phase 230 sites📍 Hefei📍 Beijing📍 Fuzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQB6411 Injection A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma NCT06767800Phase 239 sites📍 Fuyang📍 Lu'an📍 Maanshan Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQB2102 for injection (7.5 mg) +Benmelstobart+Chemotherapy, TQB2102 for injection (6 mg/7.5 mg) +Benmelstobart+Chemothe… A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC NCT06844474Phase 21 site📍 Beijing Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-1826;Adebrelimab;SHR-8068;Bevacizumab To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma NCT07179484n/a1 site📍 Beijing Beijing GoBroad Hospital · Tests: CT041 autologous CAR T-cell injection A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease NCT07262476Phase 31 site📍 Shanghai Minghui Pharmaceutical (Hangzhou) Ltd · Tests: MHB018A injection Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU NCT07391618Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: mFOLFOX/FOLFIRI ( Standard Chemotherapy) A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360Phase 317 sites📍 Birmingham📍 Walnut Creek📍 Miami GlaxoSmithKline · Tests: MMRVNS, MMRV Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma NCT07237425Phase 13 sites📍 Taipei📍 New Taipei City📍 Taipei Glonova Pharma Co., Ltd · Tests: Ronkyla Plus, Placebo, Kybella The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis NCT07363876NA1 site📍 Taichung Taichung Veterans General Hospital · Tests: Therapeutic Ultrasound, Intra-articular corticosteroid injection NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors NCT05881525Phase 11 site📍 Chongqing TCRCure Biopharma Ltd. · Tests: TC-N201 cells, IL-2, Fludarabine, Cyclophosphamide, Nab-paclitaxel A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer NCT07539155Phase 1, Phase 21 site📍 Little Rock University of Arkansas · Tests: Intratumoral MMR Injection Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents NCT07693426Phase 15 sites📍 Beijing📍 Wuhan📍 Shenyang Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. · Tests: Efsubaglutide Alfa 5 mg QW, Efsubaglutide Alfa 10 mg QW, Efsubaglutide Alfa 20 mg QW, Efsubaglutide Alfa placebo Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients NCT06572085Phase 41 site📍 Beijing Tang Ziren · Tests: Butylphthalide and Sodium Chloride Injection, Saline Solution Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections NCT06894017n/a1 site📍 Glostrup Municipality Copenhagen University Hospital, Rigshospitalet · Tests: Ozurdex (dexamethasone) A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight NCT07842640Phase 11 site📍 Baltimore Ascletis Pharma (China) Co., Limited · Tests: ASC35 Injection B, for subcutaneous use, ASC35 Placebo Injection B, for subcutaneous use, Tirzepatide Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes NCT07599982NA6 sites📍 Baltimore📍 Detroit📍 Albany DreaMed Diabetes · Tests: MODI Algorithm Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) NCT07359235Phase 11 site📍 Wuhan Tongji Hospital · Tests: KD01(the recombinant oncolytic adenovirus) A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus NCT07347080EARLY Phase 11 site📍 Luoyang The First Affiliated Hospital of Henan University of Scienc… · Tests: Exenatide Circular RNA-Lipid Nanoparticle Injection( CR059)) The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections NCT07496203NA1 site📍 Ankara Hacettepe University · Tests: BETY Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty(TKA) NCT07127042Phase 21 site📍 Chengdu ScinnoHub Pharmaceutical Co., Ltd. · Tests: Low-dose BT-114143, High-dose BT-14143, Tranexamic Acid (IV) QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788Phase 21 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Iparomlimab and Tuvonralimab Injection (QL1706), Bevacizumab, Hepatic Arterial Infusion Chemotherapy with Raltitrexed a…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy